Departure or Appointment of Directors or Certain Officers
→
12/22/25
Exec Change
Departure or Appointment of Directors or Certain Officers
→
12/15/25
Exec Change
Departure or Appointment of Directors or Certain Officers
→
10/23/25
Other
Other Events
→
8/14/25
Exec Change
Departure or Appointment of Directors or Certain Officers
→
6/27/25
Vote
Submission of Matters to a Vote of Security Holders
→
↓
Prospectuses & Registrations
19 shown
Filed
Form
Description
3/5/26
S-8
S-8
→
5/16/25
ARS
ARS
→
2/27/25
S-8
S-8
→
10/22/24
F-3ASR
F-3ASR
→
5/14/24
424B3
424B3
→
5/7/24
F-3
F-3
→
↓
Filing History(240 filings)
TypeDateAccessionPeriodSize
S-8
Mar 5, 2026
0001193125-26-093921S-8
—
247.7 KB
10-K
Mar 5, 2026
0001193125-26-09259110-K
Dec 31, 2025
15.9 MB
8-K
Mar 5, 2026
0001193125-26-0925788-K
Mar 5, 2026
18.1 MB
4
Feb 13, 2026
0001104659-26-014603OWNERSHIP DOCUMENT
Aug 3, 2025
12.7 KB
SCHEDULE 13G/A
Feb 9, 2026
0000908834-26-000072
—
6.4 KB
4
Jan 6, 2026
0002048873-26-000002
Jan 2, 2026
5.5 KB
4
Jan 6, 2026
0001226020-26-000002
Jan 2, 2026
5.3 KB
4
Jan 6, 2026
0001639860-26-000002
Jan 2, 2026
5.6 KB
4
Jan 6, 2026
0001766456-26-000002
Jan 2, 2026
5.6 KB
4
Jan 6, 2026
0001717972-26-000003
Jan 2, 2026
5.4 KB
4
Dec 22, 2025
0001307218-25-000003
Dec 18, 2025
5.5 KB
4
Dec 22, 2025
0002048873-25-000005
Dec 22, 2025
5.5 KB
3
Dec 22, 2025
0002048873-25-000004
Dec 14, 2025
14.3 KB
8-K/A
Dec 22, 2025
0001193125-25-3286848-K/A
Dec 14, 2025
209.4 KB
8-K
Dec 22, 2025
0001193125-25-3275758-K
Dec 18, 2025
202.1 KB
8-K
Dec 15, 2025
0001193125-25-3191568-K
Dec 14, 2025
236.3 KB
10-Q
Nov 6, 2025
0001193125-25-26811610-Q
Sep 30, 2025
7.0 MB
8-K
Nov 6, 2025
0001193125-25-2681028-K
Nov 6, 2025
475.4 KB
8-K
Oct 23, 2025
0001193125-25-2476928-K
Oct 23, 2025
236.7 KB
8-K
Aug 14, 2025
0001193125-25-1803138-K
Aug 11, 2025
175.1 KB
10-Q
Aug 7, 2025
0000950170-25-10459310-Q
Jun 30, 2025
8.3 MB
8-K
Aug 7, 2025
0001193125-25-1749588-K
Aug 7, 2025
259.3 KB
4
Aug 4, 2025
0001104659-25-073386OWNERSHIP DOCUMENT
Jul 31, 2025
8.0 KB
4
Jul 31, 2025
0001104659-25-072499OWNERSHIP DOCUMENT
Jul 29, 2025
8.0 KB
4
Jul 23, 2025
0001104659-25-069944OWNERSHIP DOCUMENT
Jul 21, 2025
8.0 KB
25 filings shown
Silence Therapeutics plc — SlamSEC
Proxies
2 shown
Filed
Form
Description
5/16/25
DEF 14A
DEF 14A
→
5/6/25
PRE 14A
PRE 14A
→
Ownership
40 shown
Filed
Form
Description
2/13/26
4
OWNERSHIP DOCUMENT
→
1/6/26
4
4
→
1/6/26
4
4
→
1/6/26
4
4
→
1/6/26
4
4
→
1/6/26
4
4
→
↓
Other Filings
35 shown
Filed
Form
Description
2/9/26
SCHEDULE 13G/A
SCHEDULE 13G/A
→
6/25/25
SCHEDULE 13D/A
SCHEDULE 13D/A
→
5/15/25
SCHEDULE 13G/A
SCHEDULE 13G/A
→
5/8/25
SCHEDULE 13D/A
SCHEDULE 13D/A
→
4/24/25
SCHEDULE 13D/A
SCHEDULE 13D/A
→
3/31/25
SCHEDULE 13D/A
SCHEDULE 13D/A
→
↓
Silence Therapeutics is a London-based pharmaceutical company formed in 1994. The company has pioneered the development of short-interfering ribonucleic acid (siRNA) therapeutics for the treatment of rare diseases.